Suppressor of cytokine signaling protein family (SOCS)

The suppressor of cytokine signaling (SOCS) protein family consists of eight intracellular proteins (CISH and SOCS1–7) that act as essential negative feedback regulators of cytokine and growth factor signaling [1, 5, 14]. These proteins primarily modulate the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway by binding to activated JAKs or cytokine receptors via their Src-homology 2 (SH2) domains [4, 8, 14]. A hallmark of the family is the C-terminal SOCS box, which recruits an E3 ubiquitin ligase complex to target signaling molecules for proteasomal degradation [12, 17]. SOCS1 and SOCS3 are unique in possessing a kinase inhibitory region (KIR) that functions as a pseudosubstrate to directly inhibit JAK catalytic activity [2, 13, 15]. Dysregulation of SOCS proteins is strongly linked to chronic inflammatory diseases, autoimmune disorders, and various cancers, where the loss of these regulators leads to uncontrolled cell proliferation and pathological immune responses [1, 9, 12]. Therapeutic strategies currently under investigation include the use of SOCS1/3 peptide mimetics to suppress hyper-inflammation and SOCS antagonists to enhance anti-tumor immunity or prevent viral hijacking of these regulatory pathways [7, 11, 13].

Other names

SOCS familySTAT-induced STAT inhibitor (SSI) familyCytokine-inducible SH2-containing (CIS) protein familyJAK-binding (JAB) proteinSuppressor of cytokine signaling proteins

Feedback inhibition of JAK/STAT signaling via direct Janus kinase (JAK) inhibition, competitive binding to cytokine receptors, and recruitment of E3 ubiquitin ligase machinery for the proteasomal degradation of signaling components.